In summary, the recurrent RAD51C c.571 + 4A > G variant is associated with cancers that occur in two or more heterozygotes include BC, diagnosed in five females (age range: 37–77) and OC, diagnosed in four females (age range: 41–67). Here, RAD51C is linked to breast cancer.